US76090R2004 - Common Stock
RESHAPE LIFESCIENCES INC
NASDAQ:RSLS (12/20/2024, 8:00:01 PM)
4.38
-0.09 (-2.01%)
ReShape Lifesciences Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in San Clemente, California and currently employs 31 full-time employees. The company went IPO on 2016-10-06. ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
RESHAPE LIFESCIENCES INC
1001 Calle Amanecer
San Clemente CALIFORNIA 92673
P: 19494296680
CEO: Andrew Rasdal
Employees: 29
Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the...
Conference Call to be Held at 4:30 pm ET on Thursday, November 14, 2024
Conference Call to be Held at 4:30 pm ET on Thursday, November 14, 2024...
FLEX Technology Designed to Improve the Patient Experience
FLEX Technology Designed to Improve the Patient Experience...
Here you can normally see the latest stock twits on RSLS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: